Frankfurt
24.04.26 | 08:03
0,110 Euro
-1,35 % -0,002
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.04. | BioPorto A/S: Grant of Warrants | 3 | GlobeNewswire (USA) | ||
| 13.04. | BioPorto A/S: Major Shareholder Announcement | 2 | GlobeNewswire (USA) | ||
| 08.04. | BioPorto A/S: BioPorto Successfully Completes Divestment of its Antibody Business to Janel Life Sciences, LLC | 333 | GlobeNewswire (Europe) | April 8, 2026 Company Announcement No. 7 BioPorto Successfully Completes Divestment of its Antibody Business to Janel Life Sciences, LLC COPENHAGEN, DENMARK and BOSTON, MA, USA, April 8, 2026 - BioPorto... ► Artikel lesen | |
| BIOPORTO Aktie jetzt für 0€ handeln | |||||
| 31.03. | BioPorto A/S: BioPorto Advances U.S. Adult Urine NGAL Program with FDA Pre-Submission Request After Positive EPACRA AKI Cut Off Analysis | 262 | GlobeNewswire (Europe) | March 31, 2026Announcement no. 6 BioPorto Advances U.S. Adult Urine NGAL Program with FDA Pre-Submission Request After Positive EPACRA AKI Cut Off Analysis COPENHAGEN, DENMARK, 31 March 2026 - BioPorto... ► Artikel lesen | |
| 31.03. | BioPorto A/S: KDIGO publishes 2026 Clinical Practice Guideline Draft for Acute Kidney Injury and Acute Kidney Disease | 1 | GlobeNewswire (USA) | ||
| 26.03. | Notice convening the Annual General Meeting in BioPorto A/S | 1 | GlobeNewswire (USA) | ||
| 26.03. | BioPorto A/S: BioPorto announces the Annual Report for 2025 | 257 | GlobeNewswire (Europe) | March 26, 2026Announcement no. 04BioPorto announces the Annual Report for 2025 Copenhagen, Denmark, March 26, 2026, (GLOBE NEWSWIRE) - BioPorto A/S CVR-no. 17500317 (BioPorto or company) (CPH:BIOPOR)... ► Artikel lesen | |
| 18.03. | BioPorto A/S: BioPorto Successfully Completes Preliminary Analysis of U.S. Adult NGAL Cutoff Study; Pre-Submission expected by End of Q1 2026 | 167 | GlobeNewswire (Europe) | March 18, 2026Announcement no. 03 BioPorto Successfully Completes Preliminary Analysis of U.S. Adult NGAL Cutoff Study; Pre-Submission expected by End of Q1 2026 COPENHAGEN, DENMARK, March 18, 2026... ► Artikel lesen | |
| 09.02. | BioPorto A/S Appoints Chief Financial Officer | 223 | GlobeNewswire (Europe) | February 9, 2026Announcement no. 2 BioPorto A/S Appoints Chief Financial Officer BioPorto A/S (BioPorto) (CPH:BIOPOR) today announced the appointment of Klaus Juhl Wulff as its new Executive Vice... ► Artikel lesen | |
| 05.02. | BioPorto A/S: BioPorto provides Preliminary Unaudited 2025 Financial Figures, Financial Guidance for 2026 and a Business Update | 159 | GlobeNewswire (Europe) | February 5, 2026Announcement no. 1 BioPorto provides Preliminary Unaudited 2025 Financial Figures, Financial Guidance for 2026 and a Business Update ... ► Artikel lesen | |
| 11.12.25 | BioPorto A/S: Changes to the Executive Management | 229 | GlobeNewswire (Europe) | December 11, 2025 Announcement no. 29Changes to the Executive Management COPENHAGEN, DENMARK and BOSTON, MA, USA, December 11, 2025 (GLOBE NEWSWIRE) - BioPorto A/S ("BioPorto") (CPH:BIOPOR) announced... ► Artikel lesen | |
| 24.11.25 | BioPorto A/S - admittance to trading and official listing of new shares due a private placement | 219 | GlobeNewswire | The share capital of BioPorto A/S has been increased. The admittance to trading and official listing will take effect as of 26 November 2025 in the ISIN below.
ISIN:
DK0011048619
Name:
BioPorto
Volume... ► Artikel lesen | |
| 24.11.25 | BioPorto A/S: Managers' transactions | 1 | GlobeNewswire (USA) | ||
| 24.11.25 | BioPorto A/S raises approximately DKK 43 million in new capital round - Change in number of shares and votes | 2 | GlobeNewswire (USA) | ||
| 19.11.25 | BioPorto A/S: BioPorto Interim Result for the Third Quarter of 2025 - Continued progress and continued NGAL sales growth | 371 | GlobeNewswire (Europe) | November 19, 2025 Announcement no. 26 BioPorto Interim Result for the Third Quarter of 2025 - Continued progress and continued NGAL sales growth. Copenhagen, Denmark, November 19, 2025, (GLOBE NEWSWIRE)... ► Artikel lesen | |
| 13.11.25 | Private placement of 40,438,426 new shares fully subscribed - gross proceeds of approximately DKK 43 million to BioPorto A/S | 188 | GlobeNewswire (Europe) | 13 November 2025 Announcement no. 25Private placement of 40,438,426 new shares fully subscribed - gross proceeds of approximately DKK 43 million to BioPorto A/S Copenhagen, Denmark, 13 November 2025... ► Artikel lesen | |
| 13.11.25 | BioPorto Executes on its Financing Strategy- BioPorto A/S initiates pre-subscribed private placement | 172 | GlobeNewswire (Europe) | 13 November 2025 Announcement no. 24 THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR... ► Artikel lesen | |
| 04.11.25 | BioPorto A/S: Progress Update on BioPorto's Adult Clinical Study | 168 | GlobeNewswire (Europe) | November 4, 2025Announcement no. 21 Progress Update on BioPorto's Adult Clinical Study Copenhagen, Denmark, November 4, 2025, (GLOBE NEWSWIRE) - BioPorto A/S ("BioPorto" or the "Company") (CPH:BIOPOR)... ► Artikel lesen | |
| 04.11.25 | BioPorto A/S: Pre-announcement of the Key Financial Results for Third Quarter 2025 and Revised Guidance for 2025 | 205 | GlobeNewswire (Europe) | November 4, 2025 Announcement no. 22 Pre-announcement of the Key Financial Results for Third Quarter 2025 and Revised Guidance for 2025 Copenhagen,... ► Artikel lesen | |
| 04.11.25 | BioPorto A/S: Business Strategy Update - the "Forward" Strategic Direction, Aspirations towards 2028 and Funding Needs | 221 | GlobeNewswire (Europe) | November 4, 2025Announcement no. 23 Business Strategy Update - the "Forward" Strategic Direction, Aspirations towards 2028 and Funding Needs Copenhagen, Denmark, November 4, 2025, (GLOBE NEWSWIRE)... ► Artikel lesen |
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIONTECH | 89,65 | -0,83 % | Mesoblast: Nächster Technologiesprung - und ein Sektor in Bewegung | ||
| EVOTEC | 5,220 | -3,33 % | Insiderverkäufe, Kaufempfehlungen und KI-Fantasie: BioNTech, Evotec, Vidac Pharma Aktie. | Insiderverkäufe bei Vidac Pharma. Dies ist jedoch kein Alarmsignal, sondern bietet eher eine Einstiegschance. Das Unternehmen arbeitet an einer revolutionären Krebstherapie. In 2026 sollen wichtige... ► Artikel lesen | |
| BB BIOTECH | 49,000 | -1,01 % | Umbau bei BB Biotech zahlt sich aus: Aktie schlägt Index trotz Gegenwind | BB Biotech startet solide ins Jahr 2026: Outperformance beim Aktienkurs, aktiver Portfolio-Umbau und mehr Diversifikation. Die Beteiligungsgesellschaft BB Biotech hat im 1. Quartal ein insgesamt solides... ► Artikel lesen | |
| MEDIGENE | 0,020 | -21,09 % | Medigene: Zurückziehung - 18.11.2025 | ||
| QIAGEN | 32,350 | -0,58 % | Aktien New York Ausblick: Moderate Gewinne - Lage in Nahost sorgt für Vorsicht | NEW YORK (dpa-AFX) - Am US-Aktienmarkt werden am Dienstag zum Handelsstart moderate Gewinne erwartet. Angesichts der unsicheren Lage in Nahost dominiert - wie bereits zum Wochenstart - die Vorsicht.... ► Artikel lesen | |
| MODERNA | 44,300 | -1,99 % | Moderna, Inc.: Moderna Announces Initiation of Phase 3 Study of Investigational mRNA Pandemic Influenza Vaccine Candidate | Phase 3 study is supported by the Coalition for Epidemic Preparedness Innovations to help strengthen global preparedness against a significant pandemic threat CAMBRIDGE, MA / ACCESS Newswire / April... ► Artikel lesen | |
| PAION | 0,086 | +34,65 % | PAION AG: Schwächesignal im Fokus der Analyse | ||
| VALNEVA | 2,331 | -2,10 % | Valneva vor kritischer Marke: Das Warnsignal das die meisten Anleger jetzt übersehen - Was erfahrene Trader jetzt tun! | ||
| AMGEN | 293,75 | -1,54 % | Amgen Announces Retirement Of David M. Reese, Executive Vice President And Chief Technology Officer | Organizational Changes Further Emphasize Integration of Biology and Technology
THOUSAND OAKS, Calif., April 22, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced... ► Artikel lesen | |
| EPIGENOMICS | 0,930 | +5,68 % | PTA-HV: Epigenomics AG: Einladung zur ordentlichen Hauptversammlung | DJ PTA-HV: Epigenomics AG: Einladung zur ordentlichen Hauptversammlung
Hauptversammlung gemäß -- 121 Abs. 4a AktG
Epigenomics AG: Einladung zur ordentlichen Hauptversammlung
Heidelberg... ► Artikel lesen | |
| NOVAVAX | 6,940 | -0,43 % | Novavax (NVAX) Dips More Than Broader Market: What You Should Know | ||
| BIOGEN | 160,54 | -0,21 % | Biogen To Acquire TJ Bio's Rights To Felzartamab In The Greater China Region | WESTON (dpa-AFX) - Biogen Inc. (BIIB) and TJ Biopharma have entered into a definitive agreement under which Biogen has agreed to acquire TJ Bio's exclusive rights to felzartamab in the Greater... ► Artikel lesen | |
| BIOFRONTERA | 2,520 | -0,79 % | Biofrontera: 2025 war ein richtungsweisendes Jahr | Leverkusen (www.anleihencheck.de) - Biofrontera: 2025 war ein richtungsweisendes Jahr - AnleihenewsAnbei eine aktuelle Pressemitteilung der Biofrontera AG (ISIN DE000A4BGGM7/ WKN A4BGGM)- Im dritten... ► Artikel lesen | |
| HEIDELBERG PHARMA | 2,720 | +0,74 % | EQS-News: Heidelberg Pharma AG: Heidelberg Pharma gibt Veränderung im Vorstand bekannt | EQS-News: Heidelberg Pharma AG
/ Schlagwort(e): Personalie
Heidelberg Pharma gibt Veränderung im Vorstand bekannt
17.04.2026 / 09:38 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
| ILLUMINA | 107,68 | +0,34 % | Illumina Expands Collaboration With Labcorp To Advance Precision Oncology | SAN DIEGO (dpa-AFX) - Illumina, Inc. (ILMN), Wednesday announced an expanded collaboration with Labcorp to advance precision oncology through innovative applications of next-generation sequencing... ► Artikel lesen |
Das Unternehmen BIOPORTO A/S kann der Branche Biotechnologie zugeordnet werden. Die relative Kursveränderung beträgt aktuell -1,35 % bei einem Aktienkurs von 0,110 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BIOPORTO A/S finden Sie auf Wallstreet Online.